CD274 and neoplasm: The anti-Programmed Death Ligand 1 (PDL-1) durvalumab is the gold standard in unresectable locally advanced PDL-1 positive (tumor proportion score > 1%) Non-Small Cell Lung Cancer (NSCLC) as maintenance treatment after definitive chemoradiotherapy.